Norbrook announce appointment of Liam Nagle as Chief Executive

Norbrook, the Newry-based company which is a world leader in veterinary pharmaceuticals, has announced the appointment of Liam Nagle as Chief Executive, with effect from the beginning of February 2015. Liam joins Norbrook from the SISK Group where he has been Chief Executive, and latterly Chairman, of Sisk's construction and healthcare businesses. Commenting on the appointment, Chairman Sir Roy McNulty said: "We are delighted to welcome Liam to Norbrook as Chief Executive. He brings a wide range of skills and experience which will be of great benefit to the team in Norbrook. The Company has a strong track record of innovation and growth, and we look forward to working with Liam in making the most of the opportunities we see ahead." Norbrook Deputy Chair, Lady Ballyedmond said: "I am very pleased that Liam is joining us and I am sure that, with his leadership and energy, we can together create a further successful phase in Norbrook's development". Liam Nagle said: "I am honoured to be offered the role as Chief Executive of Norbrook, the business is in an excellent position and I am excited about working with the team to build on its success and take the business to even greater heights." - ENDS - Notes to editors Norbrook is a global leader in the development and manufacture of veterinary and animal health medicines. The Group is privately owned by the Haughey family and was originally founded by the late Lord Ballyedmond in 1969. The Norbrook group is now present in 115 countries with sales of £210m in the Company's most recent financial year to July 2014. The worldwide animal health market is valued at £14 billion and over the past 7 years, Norbrook has doubled its sales through organic growth of existing products and the development and launch of new innovative medicines. Liam Nagle joined the SISK Group in 2005 as head of its non-construction trading activities and to spearhead the development of a strategy to diversify the business. Sisk entered the Healthcare sector and initially acquired a number of businesses in Ireland and the UK and have since built a very significant business of scale. Liam was appointed CEO in early 2008. The group, which was established in 1850, is in its fifth generation of ownership by the Sisk Family and is one of the largest privately owned businesses in Ireland. On joining the SISK Group, Nagle brought over 20 years international business experience in finance, operations, marketing and mergers and acquisitions to his new role. He was a senior executive at Intel from 1994 to 1997 and led the start up for Bay Networks Europe as Vice-President (1997-1998). When Nortel Networks acquired Bay Networks in 1998, he held a number of senior roles in Nortel. In 2003, Nagle became Vice-President and Chief Operating Officer of Bookham Technology. He was appointed President and Chief Operations Officer in 2004. Contact Róisín Hughes, Corporate Communications Manager: [email protected]; + 44 (0) 28 302 60200 Disclaimer The information contained in this release is as of 24 November 2014. Norbrook Laboratories Ltd. assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. Posted on Nov 24, 2014 - 02:00 PM

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…